This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Viscos, LLC Launches New Product, Play Again™, At

INDIANAPOLIS, Jan. 15, 2014 /PRNewswire/ --  Viscos, LLC announced today the launch of Play Again ™, a clinically proven formula daily supplement for joint health, discomfort and recovery, on (NYSE: GNC), the nation's largest specialty retailer of health, wellness and sports nutrition products.  This launch expands availability to consumers of all ages who are actively looking for alternative pain management solutions, joint, ligament and tendon maintenance and long term preventative products. 

Play Again is a great tasting dietary supplement that is comprised of high molecular weight hyaluronic acid (HA) as the only active ingredient.  It is packaged in a 16 oz. bottle to consume 75mg to 225 mg daily as a replenishment of hyaluronic acid (HA), a naturally occurring molecule in the body.  HA is in the synovial fluid that coats and protects all the organs, connective tissues and joints.  HA provides hydration and cushioning.  Our formulation allows the HA to be quickly absorbed for bioavailability dispersed into the extra-cellular matrix throughout the entire body.  This formula is caffeine and gluten free, and contains zero carbs or calories.

In late 2011, Play Again was launched by Viscos, LLC in the Indianapolis market.  Shortly after launch, Play Again was quickly recognized by local orthopedic surgeons, sports medicine physicians, physical therapists and athletic trainers as an effective alternative for joint and connective tissue problems seen in their patients daily.  Viscos, LLC began a double-blind randomized clinical trial in early 2013, which is still ongoing, to obtain data for efficacy and safety of Play Again.  Debbie Ecksten, President states, "The importance of having this clinical data for medical professionals and consumers should be a priority for any manufacturer now more than ever.  This trial is the best decision we have made in the short life of our company.  There are many supplements in the market that provide claims without any strong clinical evidence." 

2013 ended as great growth for Viscos, LLC and Play Again.  Viscos, LLC market survey showed over 50% of purchasers of Play Again had a recommendation from a medical professional or an endorsement from a professional athlete.  Play Again has been become a daily supplement for many pro athletes.  Combined with our physician recommendations, rapidly developing social media penetration, increased use by athletes and active people of any age, Play Again is becoming the premium supplement in this category.  Viscos, LLC is receiving inquiries worldwide and looking forward to an international distribution by Q4 of 2014.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs